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Objective: The purpose of this study was to compare cost and efficacy of 
surgical closure of patent ductus arteriosus using new critical pathway 
methods with outpatient transcatheter coil occlusion of patent ductus arteri- 
osus. Methods: Surgical techniques included a transaxillary, muscle-sparing 
thoracotomy, triple ligation of the patent ductus arteriosus, no chest tube, and 
discharge from the hospital within 24 hours. Transcatheter coil occlusion of 
patent ductus arteriosus was done as an outpatient procedure. Costs were 
compared with inclusion of all hospital and professional charges. Results: From 
July 1994 until March 1996, 20 patients underwent coil occlusion of patent 
ductus arteriosus and 20 patients underwent surgical closure of patent ductus 
arteriosus. Duration of hospitalization was significantly less for the patients 
receiving coil occlusion (11 - 6 hours) as compared with that for the patients 
having surgical ligation (28 + 7 hours, p < 0.05). Total charges were similar 
for surgical ligation ($7101 -+ $408) as compared with those for coil occlusion 
($7104 - $886, p > 0.05). Morbidity in coil occlusion included inability to 
occlude the patent ductus arteriosus in two patients (2/20, 10%) and residual 
patency in two patients (2/18, 11%). Morbidity in the surgical group included 
nausea nd vomiting necessitating hospitalization for more than 36 hours in 
one patient (1/20, 5%), transient left recurrent laryngeal nerve palsy in one 
(1/20, 5%), and pneumothorax in two patients (2/20, 10%). There were no 
instances of residual patency in the surgical group. Conclusions: Transaxillary 
thoracotomy without tube thoracostomy and with critical pathway methods 
allows safe and effective ligation of a patent ductus arteriosus with early 
hospital discharge. This surgical method has similar cost, higher efficacy rate, 
and applicability in all patients as compared with newer transcatheter coil 
occlusion techniques for closure of a patent ductus arteriosus. (J Thorac 
Cardiovasc Surg 1996;112:1634-9) 
T reatment of patent ductus arteriosus (PDA) has traditionally been surgical with ligation or divi- 
sion of the ductus arteriosus through a thoracotomy 
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incision. 1'2 Newer transcatheter therapies have 
emerged in the past several years with the introduc- 
tion of the Rashkind occluder device s and occlusion 
with the use of Gianturco coils. 4 Recent surgical 
techniques have also been developed to ligate a 
PDA with use of "minimally invasive" thoracoscopic 
methods? Controversy exists concerning the cost, 
efficacy, and complication rates for surgical closure 
as compared with transcatheter closure of a ductus 
arteriosus. One large multicenter study has demon- 
strated surgical igation of a PDA to be more cost 
effective and to have a higher efficacy rate than 
transcatheter ductal occlusion with the Rashkind 
occluder device. 3Similar comparisons have demon- 
strated that transcatheter coil occlusion is more cost 
effective and just as efficacious as surgical liga- 
tion.6, 7 
Current trends in critical pathway methods in 
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Table I. Results of transcatheter coil occlusion and surgical igation in 40 patients 
Coil occlusion Surgical ligation 
Patients (n) 20 
Age 4.1 _+ 4.9 yr (range 6 mo-15 yr) 
Weight (kg) 18 _+ 16 
Procedure length (min) 101 + 42 
Duration of hospitalization (hr) 11 _+ 6 
Total charges ($) 7105 _+ 886 
Color Doppler patency (n) 2 (2/18, 11%) 
20 
3 -+ 3.9 yr (range 4 mo-10 yr) 
12- -7  
46 _+ 6* 
27 _+ 6* 
7101 -+ 407 
0 (0/20, 0%) 
*p < 0.05. 
operations for congenital heart disease s have led us 
to use techniques that allow operation for PDA with 
early hospital discharge and minimal morbidity. This 
study compares current costs and efficacy of surgical 
ligation with those of newer transcatheter coil oc- 
clusion techniques for the treatment of PDA. 
Material and methods 
Patient population. Between July 1994 and March 
1996, nonneonatal patients with isolated PDA were given 
the option of closure of the PDA by thoracotomy and 
surgical igation or by transcatheter coil occlusion. Pa- 
tients were not randomized to one treatment or the other, 
but rather were selected for coil occlusion on the basis of 
patient preference and the presence of a ductus arteriosus 
that appeared to be relatively small (<-5 mm) on preop- 
erative echocardiography and color Doppler evaluation. 
Patients were referred for operative closure on the basis 
of patient preference for operation or the presence of a 
ductus arteriosus thought o be too large for coil occlu- 
sion. July 1994 coincided with the time we began to use 
critical pathway methods and axillary thoracotomy to 
reduce cost and resource utilization for surgical patients 
with PDA. This also coincided with the period when 
transcatheter coil occlusion techniques were introduced at 
our institution to close small PDAs. 
All patients underwent a routine preprocedure evalua- 
tion with electrocardiography, chest roentgenography, 
and echocardiography. Surgical patients were admitted to 
the hospital the day of operation and duration of hospi- 
talization was determined from the time of operation to 
the time of hospital discharge. Patients who underwent 
transcatheter coil occlusion were not admitted to the 
hospital and underwent the procedure on an outpatient 
basis. 9 Duration of hospitalization for coil occlusion was 
defined as the time from the coil occlusion procedure to 
discharge home. All patients underwent late evaluation 
for the presence of residual patency with the use of 
color-flow Doppler echocardiography and successful oc- 
clusion was defined as no evidence of any residual flow. 
Techniques. Surgical patients were admitted to the 
hospital the day of operation and underwent operation 
with use of general anesthesia. Operative exposure was 
attained through a small axillary thoracotomy in the third 
intercostal space made posterior to the pectoralis major 
muscle and anterior to the latissimus dorsi muscle. 1° The 
PDA was then ligated with a triple ligature technique. No 
tube thoracostomy was done and fluid in the chest was 
aspirated before chest closure. An extrapleural, intercos- 
tal catheter 11 was inserted before chest closure for the 
administration of 0.25% bupivacaine every 4 to 6 hours in 
the postoperative period. After operation the patients 
were not admitted to an intensive care unit but were 
admitted to a standard ward after a short stay in the 
postanesthesia c re unit. Discharge from the hospital was 
planned on the next morning after operation. 
Standard techniques were used for transcatheter occlu- 
sion of the ductus arteriosus with the use of Gianturco 
coils. 4 All transcatheter p ocedures were done with intra- 
venous edation and local anesthesia. Patients underwent 
aortography both before and after coil placement o 
document immediate occlusion and placement of the coil 
or coils. 
Data analysis. Data were obtained for all patients from 
retrospective r view of hospital records. All direct costs to 
the patient were included and were quantified according 
to actual charges to the patient. These included all 
hospital charges and physician fees for the procedure 
including follow-up visits in the first month after the 
procedure. Preprocedure diagnostic tests were not in- 
cluded in the total costs. All postprocedure echocardio- 
grams were done free of charge as part of the study and 
were not included in the cost analysis. Indirect costs such 
as parental absence from work and psychologic and social 
costs of pain and thoracotomy were not quantified or 
included in the analysis. All patients were contacted 
through direct clinic visits to document any out-of-hospi- 
tal complications. 
Results are described as mean plus or minus the 
standard deviation. Comparisons of means were done 
with a Student's t test and ap value <0.05 was considered 
significant. 
Results 
Table I lists data for patient age, weight, proce- 
dure length, charges, and complications in both the 
transcatheter coil occlusion and surgical ligation 
groups. There were no early or late deaths in either 
group of patients. In two patients in the coil occlu- 
sion group the PDA appeared larger than 5 mm on 
angiography and coil occlusion was not attempted. 
These two patients ubsequently underwent surgical 
ligation and are included in the surgical group, but 
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only for the costs of the procedure related to 
operation. The total charges for these two patients 
to undergo catheterization and attempted coil oc- 
clusion followed by surgical igation were $14,103 
and $13,929, respectively. Patients in the coil occlu- 
sion group underwent fluoroscopy for an average of 
16 _+ 10 minutes during the procedure. 
In the surgical group, complications occurred in 
four patients: one with a transient left recurrent 
laryngeal nerve injury, two with postoperative pneu- 
mothorax, and one with prolonged nausea and 
vomiting that necessitated hospitalization for more 
than 36 hours. Both patients with pneumothorax 
required only needle aspiration and hospitalization 
was not prolonged. One patient in the transcatheter 
coil occlusion group and one patient in the surgical 
group were admitted to the intensive care unit 
electively, early in the experience with both proce- 
dures. No patient in either group required blood 
transfusion. Late patency was found in two patients 
in the coil occlusion group and both patients had 
inaudible murmurs with patency only detectable by 
color-flow Doppler echocardiography at 1 month 
and 22 months, respectively. There have been no 
other complications in the coil occlusion group, 
including late pulmonary artery stenosis, coil embo- 
lization, or femoral artery occlusion. 
Discussion 
Since the first description by Gross and Hubbard 1
in 1939, surgical igation or division has remained 
the standard treatment for patients with PDA. 2 
Recently, less invasive techniques have gained wider 
acceptance and have included thoracoscopic clip- 
ping of the PDA, 5 Rashkind occlusion device clo- 
sure, 3 and coil occlusion of the PDA with Gianturco 
coils. 4 These newer treatment modalities have been 
perceived to cost less and be as effective as standard 
surgical techniques. 6' 12 Most of these studies have 
compared the newer modalities against standard 
thoracotomy and surgical ligation with relatively 
older patient care techniques. Use of critical path- 
way methods has had a favorable impact on length 
of stay and hospital costs when applied to children 
with congenital heart disease, including PDA. 8 In 
addition, other less traumatic techniques uch as 
muscle-sparing 13 or axillary thoracotomy and the 
avoidance of tube thoracostomy 1° have a favorable 
impact on care of the patient with PDA. We rea- 
soned the combination of these critical pathway 
techniques with muscle-sparing axillary thoracotomy 
would be the most appropriate way to compare 
transcatheter coil occlusion with surgical igation of 
a PDA. 
Previous studies have shown conflicting results 
with regard to cost of surgical approaches that used 
thoracotomy as compared with transcatheter or 
thoracoscopic techniques. In 1993 Gray and associ- 
ates 3concluded that surgical ligation was less costly 
and more effective in closure of the PDA when 
compared with use of the Rashkind PDA occluder. 
In a smaller but similar study Human and associ- 
ates 14 demonstrated almost identical costs for sur- 
gical closure and use of the Rashkind PDA occluder 
device. In their study, the surgical ligation group had 
a hospital length of stay of 5.8 days, which undoubt- 
edly contributed to costs in the surgical group. TM A 
recent study by Rothenberg and colleagues 12dem- 
onstrated thoracoscopic closure of the PDA to be 
more cost effective than a standard surgical ap- 
proach, but with a length of stay in the surgical 
group of "3 to 4 days." There is no doubt a more 
"modern" surgical cohort group with a length of stay 
of 24 to 48 hours, as in this study, would allow a 
more favorable comparison of surgical igation or 
division with video-assisted thoracoscopic ductal 
closure. Other larger series of video-assisted thora- 
coscopic ligation of PDA have not directly ad- 
dressed the question of costs. 5' 15 More recent re- 
ports of transcatheter coil occlusion techniques have 
demonstrated a lower cost for transcatheter coil 
occlusion as compared with surgical ligation, but 
have had a rather expensive comparison group for 
the surgical cohort 6' 16 as compared with the costs in 
the current study. Although length of stay was not 
described in the comparative studies by Lohr 6 and 
Fedderly 16 and their coworkers, hospital costs for 
surgical ligation, exclusive of professional fees, were 
nearly twice those in our study. 
Costs for transcatheter coil occlusion may be 
reduced even more as experience is gained. Costs 
for surgical ligation were relatively low in our series 
and nearly identical to the low costs of transcatheter 
coil occlusion (Table I). This is likely a result of the 
relatively short length of stay (mean, 28 hours) in 
the surgical group, avoidance of the intensive care 
unit, and reduction of tests and medications to only 
essentials. It is also possible that the excellent pain 
control obtained with extrapleural intercostal nerve 
block assisted with better pulmonary mechanics and 
quicker recovery, thereby allowing earlier hospital 
discharge. 1l
In our study, we quantitated only inpatient and 
subsequent outpatient hospital charges and did not 
The Journal of Thoracic and 
Cardiovascular Surgery 
Volume 112, Number 6 
Hawkins et al. 1 6 3 7 
make an attempt o quantitate indirect or social 
costs. These indirect costs can be important to 
patients' families when considering the b st option 
for a child with PDA. 3' t4 For instance, the loss of 
parent's income during absence from work and the 
psychologic and social costs of postthoracotomy 
pain and scarring were not quantitated. However, 
the surgical approach does not have potential dis- 
advantages that are hidden in the transcatheter coil 
occlusion approach such as radiation exposure from 
fluoroscopy and the possibility of the need for a 
second procedure if coil occlusion cannot be done or 
is unsuccessful. 
The efficacies of transcatheter coil occlusion, of 
use of the Rashkind PDA occluder device, and of 
operation have been documented in the literature. 
Closure of PDA with the Rashkind occluder device 
has been associated with a relatively high early 
patency rate by color Doppler echocardiography of 
25% to 35%, 3 but with much more acceptable 
long-term residual patency rates as low as 4% in 
some series. ~7 Transcatheter coil occlusion seems to 
have slightly better results, but large multiinstitu- 
tional studies have also demonstrated early (<1 
month) patency rates that approached 30%, but that 
declined to 4% in patients followed up for more 
than 6 months. 7 Thoracoscopic closure or clipping 
of the PDA also is associated with residual patency 
that has been reported as high as 10% to 12% in 
some series. 12' 15 Surgical ligation has been reported 
to have a residual patency'rate ashigh as 22%, 18 but 
this is likely dependent on the surgical technique 
used. The techniques used in the series from So- 
rensen, Kristensen, and Hansen is included only 
single suture ligation or single clipping. We would 
caution against he use of a single ligature inasmuch 
as we and others have had residual patency with use 
of this method. 2~v' 19 We believe double or triple 
ligation and, certainly, division of the PDA are 
associated with a negligible residual patency rate as 
indicated by our results and those of others 2' 14 and 
likely remain the standard by which the efficacy of 
newer therapies should be measured. 
The natural history and clinical implications of 
residual color-flow Doppler patency of a coil-treated 
or surgically treated PDA, in the absence of a 
clinically undetectable murmur, are unknown and 
would be difficult to determine. Almost all natural 
history data have been determined from patients 
who had clinically detectable murmurs and have 
been from before the era of color-flow Doppler 
echocardiography. 2° Certainly endarteritis has been 
21 reported in a patient with an inaudible murmur, 
but the likelihood is that the "clinically silent" 
residual PDA is a relatively benign "techno-malady" 
that would require a relatively large amount of 
resource utilization with potential complications to 
effectively eliminate risk in all patients. 22' 23 
Complications in our series were relatively few 
and generally not major. The major complication i  
the coil occlusion group was residual patency of the 
PDA. Although not strictly a complication of coil 
occlusion, the decision not to attempt placement of 
a coil because of PDA size represents an adverse 
outcome for a patient who enters the catheterization 
laboratory expecting to have closure of a PDA. This 
has been reported in 2.5% to 26% of patients 
undergoing attempted coil occlusion of a PDA. 6' 7 It 
is likely that with further experience better selection 
of patients by echocardiography will reduce to an 
acceptable l vel the number of patients with condi- 
tions found unsuitable for transcatheter coil closure. 
Because of our reluctance to attempt coil occlusion 
in patients with large or unfavorably shaped PDAs, 
we have had none of the complications een by 
others such as left pulmonary artery stenosis, coil 
embolization, and femoral artery occlusion or in- 
jury. Complications in the surgical group have also 
been relatively minor. Our prevalence of recurrent 
laryngeal nerve injury of 5% (Table I) is similar to 
that in larger series of surgical treatment of PDA a4 
and remains higher than the negligible or nonexist- 
ent prevalence in transcatheter techniques. It is
possible that this method of axillary thoracotomy 
could have adverse late complications such as scoli- 
osis or late thoracotomy pain, because long-term 
functional results with use of this technique are 
lacking.10, ~3, 25 It would be expected, however, that 
the minimal dissection and muscle sparing used in 
the axillary technique would have fewer adverse 
effects on pain and scoliosis than the more tradi- 
tional full lateral thoracotomy. Pneumothorax oc- 
curred in 10% of our patients, but this was a 
complication that was a result of the avoidance of
tube thoracostomy and was easily treated without 
prolongation of hospitalization. Axillary thoracot- 
omy without ube thoracostomy has been previously 
shown to be a safe technique for PDA ligation with 
a minimal occurrence of significant pneumotho- 
rax .  1° 
Surgical treatment of PDA remains the standard 
by which newer, less invasive techniques must be 
measured both in terms of cost and efficacy. 
Transaxillary, muscle-sparing thoracotomy without 
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tube thoracostomy, triple ligation, and critical path- 
way methods allow safe and effective ligation of a 
PDA with early hospital discharge. This surgical 
method has a similar overall cost, higher efficacy 
rate, and applicability in all patients as compared 
with newer transcatheter coil occlusion techniques 
for closure of PDA. Despite these advantages of 
surgical igation, coil occlusion is effective for the 
small PDA and is currently the procedure of choice 
in our institution for the smaller PDA because it 
does allow successful c osure in the vast majority of 
patients without he need for overnight hospitaliza- 
tion or a scar. Only longer term follow-up, more 
experience, and prospective evaluation of transcath- 
eter coil occlusion will determine whether this less 
invasive technique will become the standard tech- 
nique for closure of PDA. 
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Discussion 
Dr. J. Terrance Davis (Columbus, Ohio). We had a 
similar interest in doing this type of study in Columbus, 
and as we looked at our cost accounting, we found an 
interesting bias against operation. That is, the operating 
room has traditionally been considered a profit center 
and, as such, replacement expenses for all of the equip- 
ment are rolled into the charge along with some sort of 
fudge factor. On the other hand, catheterization labora- 
tory charges are done differently. The major capital 
equipment here has been funded by a capital budget, 
charges for which are not rolled into the usage fees. 
Significant personnel paid by other budget areas are also 
used in the catherization laboratory. Thus in a sense the 
hospital significantly subsidizes the catherization labora- 
tory charges, whereas the opposite is true in the operating 
room. I wondered whether the charges in this study were 
just straight charges off of the hospital bill or whether 
there was cost accounting involved. 
Dr. Hawkins. I took a rather simplistic approach to 
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looking at the charges in this, and what I tried to analyze 
was the number that patients would get if they went home, 
took all of the bills, and added them up on a pocket 
computer. This is simply the actual bills that they received. 
I am not sure about the cost accounting in our operating 
room. Our operating room is charged by the minute. I am 
sure there are some capital budget items that are built into 
this charge. The cardiac catheterization lab, I think, is 
charged on a per procedure basis and not on a per minute 
basis. However, I cannot answer your question about 
exactly the cost accounting that was done. 
Dr. Robert A. Guyton (Atlanta, Ga.). My understanding 
is that these were the first 20 coil occlusions done at the 
authors' institution. Do they really think it is fair to 
compare the first 20 with the authors' last 5%? 
Dr. Hawkins. That is a good question. You are taking 
the approach of the devil's advocate of surgical igation, 
and the results probably are not the same. I think that our 
cardiologists have learned something in these first 20 
patients. I think what they have learned to a certain extent 
is which patients in whom not to try coil occlusion. The 
other thing that I think they have learned is to not leave 
the catheterization lab with any aortographic evidence of 
residual patency. Despite the learning curve, I think in 
large multiinstitutional studies, which were just reported 
at the American College of Cardiology, there is going to 
be a residual patency rate with coil occlusion that is 
probably about in the 5% range in the long term no matter 
how this is done. My own bias is for operation. Yes, it is 
the cardiologists' first 20 patients, but to a certain extent it 
is also our first 20 patients, at least with this new tech- 
nique. Surgical ligation has been done for about 50 years, 
so some may argue it is not fair to compare. 
Dr. D. Craig Miller (Stanford, Calif.). But surgical 
ligation has not been done this way for 40 or 50 years or 
so, right? 
Dr. Hawkins. No. 
Dr. D. Glenn Pennington (Winston-Salem, N.C.). I think 
this study is important. Of course, the third alternative is
thoracoscopic closure of the PDA, and I wonder where 
the authors think that fits into this schema. 
Dr. Hawkins. We did not look at and we do not perform 
thoracoscopic closure of the PDA at our institution. I 
think the procedure is probably here to stay. I think one 
disadvantage that it has is that it requires high costs and 
high-technology material that is expensive. Personally, it is 
difficult for me to see that this short incision is that much 
different from four small incisions added up, but I am sure 
the thoracoscopic advocates would argue with me on that 
issue. 
Dr. Richard A. Jonas (Boston, Mass.). We have moved 
in Boston to using video-assisted thoracoscopic ligation of 
the ductus as a routine. In comparison with catheteriza- 
tion laboratory capital expenditure, the equipment really 
is not all that expensive. In our own practice I believe it 
has been associated with a significant decrease in charge. 
Is that the next study to be done: comparison of video- 
assisted thoracoscopic ligation of the ductus and coil 
occlusion? 
Dr. Hawkins. There has been one study of video- 
assisted thoracoscopic versus urgical ligation out of Den- 
ver by Rothenberg (Rothenberg SS, Chang JHT, Toews 
WH, Washington RL. J Pediatr Surg 1995;30:1057-60). 
His results, however, compared itwith an older method of 
surgical ligation of the PDA with hospital stays that 
averaged almost 3 days, so i do not think that is a fair 
comparison in 1996. I do agree that comparison of 
video-assisted thoracoscopic ligation with modern critical 
pathway regular surgical methods is the next step, and not 
only comparison of cost but also comparison of pain 
control and other variables on down the line. 
Dr. Miller. I believe Dr. Jonas was interested in video- 
assisted thoracoscopic ligation Versus coil occlusion. 
Do you think that is a good idea? 
Dr. Hawkins. Yes, I think it is the natural extension. 
Dr. Randall B. Griepp (New York, N.Y.). Some of us 
have thought that one of the advantages of surgical 
closure is that it is actually division and closure in which 
there is a zero incidence of recanalization. Would the 
authors feel comfortable through this incision doing a 
division and closure, particularly with a large ductus 
arteriosus? 
Dr. Hawkins. I would feel comfortable doing division 
with this technique. It is a small incision. But I do not 
totally feel comfortable doing division in every case. This 
is just a personal preference. I think triple ligation is a 
little bit easier to do without the risk of bleeding. 
